N-Butyl-L-Deoxynojirimycin (L-NBDNJ): Synthesis of an allosteric enhancer of α-glucosidase activity for the treatment of Pompe disease

The highly stereocontrolled de novo synthesis of L-NBDNJ (the unnatural enantiomer of the iminosugar drug Miglustat) and a preliminary evaluation of its chaperoning potential are herein reported. L-NBDNJ is able to enhance lysosomal α-glucosidase levels in Pompe disease fibroblasts, either when admi...

Full description

Bibliographic Details
Main Authors: D'Alonzo, D, De Fenza, M, Porto, C, Iacono, R, Huebecker, M, Cobucci-Ponzano, B, Priestman, D, Platt, F, Parenti, G, Moracci, M, Palumbo, G, Guaragna, A
Format: Journal article
Published: American Chemical Society 2017